TOBREX OPH OINT Rx
Generic Name and Formulations:
Tobramycin 0.3%; contains chlorobutanol.
Alcon Laboratories, Inc.
Indications for TOBREX OPH OINT:
Susceptible infections of conjunctiva and cornea.
Adults and Children:
Severe infections: initially 2 drops every hr or ½ inch of ointment every 3–4 hrs; then may prolong dosing interval. Mild to moderate infections: 1–2 drops every 4 hrs or ½ inch of ointment 2–3 times daily.
Remove contact lenses before using. Pregnancy (Cat.B). Nursing mothers: not recommended.
Concomitant systemic aminoglycosides: monitor levels.
Superinfection, itching, swelling, erythema, sensitivity (discontinue if occurs); oint: may retard corneal healing.
Endocrinology Advisor Articles
- FDA Approves Admelog Short-Acting Insulin Lispro Injection
- Fertility Hormone Therapy and Cardiovascular Outcomes: What We Know
- Effects of Peer Influence in Adolescents With Type 1 Diabetes
- More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes
- One-Hour Glucose Readings Predict T2D Risk Better Than 2-Hour Measurements
- FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels
- Injected and Oral Medications Equally Safe for Gestational Diabetes
- Adjunctive Dapagliflozin Improves Glycemic Control in T1D
- Estradiol Therapy May Benefit Overall Cognition in Postmenopausal Women
- Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death
- Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D
- Safety of Chronic Total Occlusion Percutaneous Coronary Intervention in Diabetes
- Oral Insulin Not a Reliable Preventive Strategy for Type 1 Diabetes
- Prevention of Bone Mineral Density Loss Needed in Epilepsy
- Gastric Bypass Blunts B-Cell Sensitivity During Glycemia